Immunohistochemistry Antibody Technical Guide

1. How to Choose Antibodies for Immunohistochemistry (Practical Checklist)

Selection, Validation, and Control Setup for Immunohistochemical Antibodies

A successful IHC experiment begins withCareful Selection and Rigorous Validation of AntibodiesSince different antibody clones target distinct epitopes of the same target protein and their performance may vary significantly across different experimental methods (such as Western Blot and IHC), it is essential to consider their validated application scenarios during selection.Clarify the experimental objectives and antigen characteristics.

1.1 Sample TypeConfirmedParaffin embedding (FFPE) vs. frozen sections

The method of sample handling directly influences antibody performance and the formulation of experimental protocols.For paraffin sections, antibodies validated for antigen retrieval should be selected, whereas antibodies for frozen sections may not be suitable for paraffin samples.

● Type of experimental sample observed

Determine whether it is a formalin-fixed, paraffin-embedded (FFPE) tissue section or a section from fresh tissue that has been directly frozen and preserved. The antigen preservation status differs between the two sample types: FFPE samples may have some antigen epitopes masked due to the fixation and dehydration processes, requiring antigen retrieval (such as heat-induced or enzymatic retrieval) to expose them. Frozen samples retain antigen structures closer to their original state, but tissue morphology may be compromised due to ice crystal formation.

● Sample Preprocessing

For FFPE samples, it is necessary to perform dewaxing (xylene immersion) and hydration (gradient alcohol to distilled water), followed by antigen retrieval (such as boiling in citrate buffer or high-pressure retrieval).

If the sample is frozen, directly remove it from -80°C and equilibrate to room temperature, then fix it with acetone or methanol (avoid formaldehyde fixation to prevent antigen cross-linking).

● Record sample status

Observe the thickness of the sections (typically 4–5 μm for FFPE and 8–10 μm for frozen samples), tissue integrity, and background color to provide a basis for subsequent result analysis.

1.2 Expected Staining Pattern and Control Settings

● Confirm the expected staining pattern of the antibody in the target tissue

Incorrect localization (e. g., nuclear staining for a protein that should be membrane-bound) may indicate non-specific binding.

Cell type: Such as epithelial cells, lymphocytes, tumor cells, etc.

Subcellular localization: Nucleus (e. g., Ki-67), cytoplasm (e. g., β-catenin), cell membrane (e. g., PD-L1), or extracellular matrix (e. g., collagen).

● Setting Controls

Positive Control: Select tissues known to express the target protein (such as ER/PR in breast cancer tissues or AQP2 in normal kidney tissues) as positive controls to validate antibody effectiveness.

Negative Control: Use isotype IgG (non-immune serum) or omit the primary antibody to confirm non-specific binding (such as background staining or false positives).

● Adjust experimental conditions according to the expected pattern

For example, if the target protein is located in the nucleus, ensure adequate antigen retrieval (e. g., high-pressure retrieval is more effective than heat retrieval); if it is a membrane protein, avoid over-fixation to prevent damage to the membrane structure. If the expected results do not match the literature, troubleshoot issues such as antibody concentration, retrieval conditions, or sample quality.

1.3 Genus and SpeciesReactivity and Experimental Background

● Species reactivity is the basis for antibody selection

First, ensure that the antibody can recognize the target protein to which it belongs.Genus(such as human, mouse, rat). Secondly, in immunohistochemistry, it is also necessary to consider the matching of the primary antibody with the species of the sample to avoid cross-reactions between the secondary antibody and endogenous immunoglobulins in the sample.Therefore, it should firstConfirm the "Genus"Reactivity" (Species Reactivity), which refers to whether the antibody can recognize the experimental sample.GenusSource (e. g., human, mouse, rat, etc.). Consideration should also be given toApplication type and specific requirements.

Application Type: Immunohistochemistry (IHC), Immunofluorescence (IF), or Flow Cytometry (FC)。Different applications require different antibody clone numbers (e. g., antibodies for IHC may undergo cross-linking modifications).

Multiplex Staining Requirements: When detecting multiple proteins simultaneously, it is necessary to select antibodies from different species (e. g., one primary antibody from rabbit, with a secondary antibody labeled anti-rabbit IgG; another primary antibody from mouse, with a secondary antibody labeled anti-mouse IgG) to avoid cross-reactions.

● Validation of Antibody Cross-Reactivity

If the experimental sample is a transgenic mouse (expressing human protein), it is necessary to confirm whether the antibody recognizes both mouse and human antigens (e. g., "Cross-reacts with human and mouse").

If the sample is non-standardGenus(such as zebrafish), the specificity of the antibody needs to be verified through Western blot pre-experiments.

Optimize antibody concentration:

Perform gradient dilution (e. g., 1: 50, 1: 100, 1: 200) and determine the optimal concentration through preliminary experiments (low background and strong signal).

● Formally commence the experiment

Process the samples under optimized conditions (fixation, permeabilization, incubation with primary/secondary antibodies).

After color development, observe the results and compare the expected pattern with the actual staining (e. g., whether the localization is consistent and the intensity is reasonable).

If the result is abnormal, review the previous three steps (sample type, expected pattern,GenusReactivity) and adjust parameters (such as changing antibodies, adjusting repair time or concentration).

1.4 Selection of Monoclonal and Polyclonal Antibodies in Immunohistochemistry (Quick Comparison)

Monoclonal antibodies and polyclonal antibodies each have their own advantages and disadvantages, and the choice depends on the specific requirements of the experiment.

For high-specificity localization (e. g., PD-L1 expression on tumor cell membranes), monoclonal antibodies are preferred.

For high-sensitivity detection (such as weak expression of inflammatory factors in paraffin-embedded tissues), polyclonal antibodies can be considered, but strict validation of specificity is required (e. g., through absorption experiments to exclude non-specific binding).

1.5 What should IHC validation evidence include?

● Specificity Verification

Competition/Spike-in Experiment: Pre-incubate the antibody with an excess of the target antigen. If the subsequent staining signal is significantly reduced or disappears, it demonstrates that the antibody specifically binds to the target protein.

Gene Knockout/Silencing Control: In cell or tissue samples where the target gene is knocked out (KO) or knocked down (e. g., via siRNA treatment), there should be minimal or no staining signal, serving as a critical basis for negative controls.

● Sensitivity Validation

Gradient Dilution Test: Determine the optimal working concentration of antibodies through serial dilution. For example, clear staining is still observed at a 1: 100 dilution, while the signal significantly weakens at 1: 200, which helps clarify the detection limit.

Low-abundance protein detection: Perform staining comparisons between tissues known to have low expression of the target protein (e. g., certain normal tissues) and tissues with high expression (e. g., corresponding tumors) to verify whether the antibody can stably detect low-level expression.

● Cross-Reactivity Validation of Species

If the antibody datasheet indicates applicability for multipleGenus(For example, "Human/Mouse Universal"), should be specified separately for differentGenusThe tissues were individually validated to ensure consistent staining patterns and to avoid artifacts caused by differences in cross-reactivity.

● Application Type Validation

Confirm that the antibody is explicitly labeled as suitable for IHC experiments, and it is recommended to refer to published IHC staining images (such as typical results in the product manual or related literature) as a basis for the expected staining pattern.

● Inter-Batch Consistency Verification

Especially for polyclonal antibodies, there may be variations between different batches. It is recommended to perform parallel staining experiments with different batches of antibodies to ensure that there are no significant differences in staining intensity and patterns.

All validation experiments should preserve complete images and data records, compiled into a validation report. For example, this may include negative control images from absorption experiments, unstained results from gene knockout samples, etc., serving as supporting materials for the reproducibility of the experiments.

If issues such as strong non-specific staining, weak signals, or no signals are observed during the verification process, it may be necessary to consider changing the antibody or further optimizing the experimental conditions, such as adjusting the antigen retrieval method or reducing the antibody concentration.

1.6 Basic Optimization Plan (Dilution + Antigen Retrieval)

In immunohistochemistry experiments, rapidly determining the optimal working conditions through a limited number of systematic tests ensures staining quality while saving time and reagents.

● Antibody Dilution Optimization

First, fix the antigen retrieval conditions (for example, using citrate buffer for high-pressure retrieval for 10 minutes), then proceed with the following steps.。

Select 3–5 dilution ratios (e. g., 1: 50, 1: 100, 1: 200, 1: 400) and perform parallel staining on the same batch of tissue samples. Compare and observe the staining results.

Optimal Dilution: The signal is clear with minimal non-specific background (e. g., strong nuclear positivity in tumor cells at 1: 200, with no staining in the surrounding stroma).

Dilutions to be excluded: Concentrations that are too high (e. g., 1: 50) can lead to excessively dark backgrounds, while concentrations that are too low (e. g., 1: 400) result in weak signals, neither of which are suitable for formal experiments.

● Optimization of Antigen Retrieval Conditions

Based on the established optimal antibody dilution, further optimize the antigen retrieval method.。

Fixed antibody dilution (e. g., 1: 200)

Compare 2–3 common repair methods:

Hot Fix: Citrate buffer is suitable for most nuclear antigens (such as Ki-67); EDTA buffer is more suitable for membrane proteins or certain difficult-to-expose antigens (such as EGFR).

Enzyme Repair: Such as Proteinase K or trypsin, typically used only in cases of severe antigen masking after formalin fixation. Usage requires strict time control to prevent tissue damage.

Based on the localization and staining clarity of the target protein, select the repair protocol with the highest signal-to-noise ratio.

● Recording of Optimization Results and Next Steps

Incorporate the finalized conditions (e. g., "antibody dilution 1: 200 + citrate buffer high-pressure retrieval for 10 minutes") into the experimental protocol as a unified standard for subsequent experiments. If the staining results remain unsatisfactory after optimization, further investigate other potential influencing factors, such as blocking time, secondary antibody concentration, or the detection system, to gradually refine the experimental system.

2. How to Validate Immunohistochemical Staining

Validation of immunohistochemical staining requires multidimensional control experiments and result evaluation: first, set up positive controls (tissues known to express the target antigen) and negative controls (blank controls or isotype controls) to confirm antibody effectiveness and non-specific background; second, evaluate staining intensity (weak/medium/strong positive) and extent (percentage of stained cells), combined with cellular localization (nuclear/cytoplasmic/membrane) to determine antigen expression patterns; simultaneously, assess the degree of background staining to exclude interference from endogenous enzymes or biotin; finally, integrate the results with clinical information and other pathological examinations (such as H&E staining) for comprehensive analysis, ensuring that the staining results align with expected biological significance, thereby guaranteeing the accuracy and reliability of the experiment.

2.1 Minimum Control Set (Baseline Control)

Each experimental batchSuggestionIncludes the following five types of controls to exclude non-specific staining, false positives/negatives, and technical errors:

● Positive OrganizationPositive Control

• Objective: To verify the binding capability of the antibody to the target antigen and the effectiveness of the chromogenic system.
• Procedure: Use tissues known to express the target antigen (e. g., ER-positive breast cancer tissue for ER antibody detection).
• Result: The organization must exhibit staining of the expected intensity and localization
• Eliminate Artifacts: If the positive control shows no staining, it suggests antibody failure, insufficient antigen retrieval, or a malfunction in the detection system.
• Common Misjudgment: Misusing low-expression tissues as positive controls, leading to false-negative conclusions.

● Negative Control

• Purpose: To eliminate non-specific binding (such as endogenous enzymes, antibody cross-reactions).
• Operation:
• Substitution control: Replace the primary antibody with non-immune serum from the same species or PBS, while keeping all other steps unchanged.
• Negative Control: Use tissues known not to express the target antigen (e. g., normal breast tissue for HER2 detection).
• Result: These areas should be clearly negative. If staining occurs, the "positive" signal in the experimental tissue is likely non-specific, and the results are unreliable.
• Eliminate Artifacts:If staining appears in the alternative control, it suggests non-specific binding of the primary antibody or insufficient blocking.
• Common Misjudgment: Incomplete blocking of endogenous peroxidase, leading to DAB background staining.

● Negative Control (No Primary Antibody Control)

• Objective:To verify that the secondary antibody does not bind directly to the tissue.
• Operation:Omit the primary antibody and directly add the secondary antibody followed by subsequent steps.
• Eliminate Artifacts: If the blank control shows coloration, it indicates secondary antibody contamination or interference from endogenous biotin in the tissue (switch to a non-biotin detection system).
• Common Misjudgment: Failure to distinguish between biotinylated and non-biotinylated secondary antibodies, leading to endogenous biotin false positives.

● Internal Control

• Purpose: To evaluate the integrity of antigen preservation and the effectiveness of antigen retrieval within the tissue.
• Operation: Compare known positive areas (e. g., tumor cells) with negative areas (e. g., stromal cells) within the same tissue.
• Eliminate Artifacts: If the positive area shows no staining, it suggests insufficient antigen retrieval or overfixation.
• Common Misjudgment: Failure to adjust retrieval conditions (such as the pH value of EDTA retrieval solution) according to the antibody instructions.

● Blocking Experiment Control

• Purpose: To verify antibody specificity (particularly for polyclonal antibodies).
• Operation: Pre-incubate the primary antibody with an excess of antigenic peptide (if known), then use for staining.
• Eliminate Artifacts: If staining disappears after blocking, it indicates good antibody specificity; if staining persists, it suggests antibody cross-reactivity.
• Common Misjudgment: Insufficient antigenic peptide used for blocking, leading to false negatives.

2.2 Reproducibility Checklist (Recorded per Batch)

To ensure the results are reproducible, the following key parameters need to be recorded:

2.3 Secondary Antibody and Detection System Selection (PracticalGuide)

● Core objective

• Specificity: Ensure that the secondary antibody binds only to the primary antibody, and the detection system displays only the target signal.
• Sensitivity: Clear staining even with low antigen expression.
• Stability: Results are not affected by endogenous components within the tissue (such as enzymes, biotin).
• Compatibility: Compatible with subsequent experiments (such as fluorescence imaging, multiplex staining).

● Secondary Antibody Selection: Key Parameters and Practical Recommendations

① Species origin of antibodies

• Rule: The species source of the secondary antibody must match the host of the primary antibody (e. g., if the primary antibody is rabbit-derived, the secondary antibody should be anti-rabbit IgG).
• Exception: If the primary antibody is a Fab fragment (lacking an Fc region), it is necessary to select a secondary antibody that targets the Fab fragment (to avoid non-specific binding of the Fc region).
• Common mistake: Using anti-mouse secondary antibodies to detect rabbit primary antibodies, resulting in a complete absence of signal.

② Mark Type

Enzyme Labeling (HRP/AP):

• Applicable scenarios: Routine light microscopy detection (such as DAB staining), sections requiring long-term preservation.
• Advantages: Low cost, stable signal (DAB precipitate can be preserved for several years).
• Disadvantages: Enzyme activity is easily affected by pH and temperature, requiring strict control of the color development time.

Fluorescent labeling (FITC/Cy3/Alexa Fluor series)：

• Applicable scenarios: Confocal microscopy, multiplex staining, live-cell imaging.
• Advantages: Intuitive signal, capable of simultaneously detecting multiple targets (via different wavelength fluorescence).
• Disadvantages: Rapid photobleaching (requires operation in the dark), and tissue autofluorescence may interfere with the results.

Biotin Labeling:

• Applicable scenarios: Detection of low-expression antigens requiring signal amplification (such as SABC/ABC systems).
• Disadvantages: Additional blocking (with free biotin or avidin) is required for tissues rich in biotin, such as the liver and kidneys.

③ Purification method

• Priority: IgG fraction (purified IgG) or Affinity-purified, to avoid interference from non-specific proteins in serum.
• Avoiding Pitfalls: If the budget is limited, opt for pre-adsorbed secondary antibodies (optimized to minimize cross-reactivity with multiple host sera).

④ Concentration Optimization

• Starting concentration: Dilute as recommended in the instructions (typically 1: 100~1: 500).
• Rapid Testing Method:

  Prepare the same tissue section and incubate with secondary antibodies at different dilutions (e. g., 1: 100, 1: 200, 1: 500).

  Select the dilution with the lowest background and strongest signal as the working concentration.

● Detection System Selection: From Basic to Advanced

① Enzyme Chromogenic System (Light Microscopy)

HRP-DAB System:

• Operation: Prepare the DAB chromogen solution immediately before use (protect from light), and control the development time to 1–10 minutes (observe under the microscope).
• Applicable Tissues: Most paraffin-embedded sections (however, for melanoma tissues, due to interference from endogenous melanin, the AP system should be used instead).
• Tip: Immediately rinse with running water after color development to stop the reaction and prevent background darkening.

AP-Fast Red/BCIP/NBT System:

• Advantages: The red (Fast Red) or blue-purple (BCIP/NBT) signal is highly distinguishable from DAB, making it suitable for double staining.
• Disadvantages: AP enzyme activity is sensitive to temperature (requires operation at room temperature to avoid inactivation at low temperatures).

② Fluorescence Detection System (Confocal/Flow Cytometry)

Monochrome Fluorescence:

• Recommended combination: FITC (green, 488 nm excitation), Cy3 (red, 561 nm excitation), DAPI (blue, 405 nm excitation).
• Pitfall Avoidance Guide: Avoid using fluorophores with overlapping emission spectra (e. g., FITC and Cy2).

Multifluorescence:

• Principle: Choose fluorophores with large differences in emission spectra (e. g., Alexa Fluor 488 + Alexa Fluor 647).
• Tool: Use a fluorescence spectrum viewer (such as Thermo Fisher's Spectra Viewer) to assist in design.

③ Chemiluminescence System (Western Blot/ELISA)

• Applicable scenarios: Requires high sensitivity for detecting protein expression (such as low-abundance targets).
• Key Points:

  When using the ECL kit, mix solution A and solution B in a 1: 1 ratio, and prepare it fresh for immediate use.

  Exposure time needs to be optimized (gradually increase from 1 second to avoid signal overexposure).

2.4 Frequently Asked Questions and Solutions